Skip to main content

CorMedix Inc 8-K, filed Nov 9, 2026

CorMedix Inc. (CRMD)

8-K 2026-11-09 For: 2026-11-08
View Original
Added on November 09, 2026

About this 8-K

CorMedix Inc filed this 8-K on November 9, 2026, reporting on events of November 8, 2026.

On November 8, 2026, CorMedix Inc. agreed to acquire substantially all Heron Therapeutics, Inc. assets for $145.0 million cash and 14,583,333 shares, plus contingent royalties and earn-outs. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 2.03: New debt or off-balance-sheet obligation
  • Item 3.02: Unregistered sale of equity
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits